Delivering >90% compliance in real-world studies
Book a demo today and see how uMotif’s eCOA/ePRO platform drives unparalleled levels of patient engagement to transform the speed, quality and accuracy of data.
Our eCOA/ePRO platform is designed for patients first to power unrivaled patient engagement and is trusted by leading pharma & biotech organizations across the globe.
We are experts in real-world patient data capture, covering all aspects of RWE – observational research, long-term follow-ups, natural history studies, non-interventional trials, and registries.
Our deep understanding and unique approach is proven to achieve >90% eCOA/ePRO compliance by engaging patients as active participants in each study. This approach has powered all study sizes, from large-scale virtual studies with over 13,000 participants, all the way down to pediatric rare disease studies with just 60 critical families.
Over 90% compliance in real-world studies
Reducing study timelines by ⅓
Capturing GCP-compliant data, ready for submission
“We needed an easy-to-use solution, that can be used across multiple countries, to manage a high volume of data capture – uMotif’s platform provides the opportunity to engage our patients”
Professor Pratik Choudhary Project Lead, King’s College London